Tonix Pharmaceuticals Holding (TNXP) Assets Average (2023 - 2025)
Historic Assets Average for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $219.9 million.
- Tonix Pharmaceuticals Holding's Assets Average rose 16606.75% to $219.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $219.9 million, marking a year-over-year increase of 16606.75%. This contributed to the annual value of $158.7 million for FY2024, which is N/A changed from last year.
- Per Tonix Pharmaceuticals Holding's latest filing, its Assets Average stood at $219.9 million for Q3 2025, which was up 16606.75% from $190.1 million recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's 5-year Assets Average high stood at $219.9 million for Q3 2025, and its period low was $82.6 million during Q3 2024.
- Its 3-year average for Assets Average is $151.3 million, with a median of $148.2 million in 2023.
- Its Assets Average has fluctuated over the past 5 years, first plummeted by 4472.04% in 2024, then soared by 16606.75% in 2025.
- Over the past 3 years, Tonix Pharmaceuticals Holding's Assets Average (Quarter) stood at $146.9 million in 2023, then decreased by 12.21% to $128.9 million in 2024, then surged by 70.54% to $219.9 million in 2025.
- Its Assets Average stands at $219.9 million for Q3 2025, versus $190.1 million for Q2 2025 and $177.9 million for Q1 2025.